image
Basic Materials - Chemicals - Specialty - NYSE - US
$ 31.67
-1.49 %
$ 1.15 B
Market Cap
-2.63
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 23, 2025.

The intrinsic value of one NGVT stock under the worst case scenario is HIDDEN Compared to the current market price of 31.7 USD, Ingevity Corporation is HIDDEN

This DCF valuation model was last updated on Apr, 23, 2025.

The intrinsic value of one NGVT stock under the base case scenario is HIDDEN Compared to the current market price of 31.7 USD, Ingevity Corporation is HIDDEN

This DCF valuation model was last updated on Apr, 23, 2025.

The intrinsic value of one NGVT stock under the best case scenario is HIDDEN Compared to the current market price of 31.7 USD, Ingevity Corporation is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart NGVT

image
$55.0$55.0$50.0$50.0$45.0$45.0$40.0$40.0$35.0$35.0$30.0$30.0$25.0$25.0Nov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 Apr
FINANCIALS
1.41 B REVENUE
-16.88%
288 M OPERATING INCOME
-0.07%
-430 M NET INCOME
-7868.52%
129 M OPERATING CASH FLOW
-37.30%
-79.5 M INVESTING CASH FLOW
-2.85%
-70.2 M FINANCING CASH FLOW
29.73%
299 M REVENUE
-20.72%
62.5 M OPERATING INCOME
-26.04%
16.6 M NET INCOME
115.49%
64.5 M OPERATING CASH FLOW
38.71%
-28 M INVESTING CASH FLOW
-60.92%
-97.6 M FINANCING CASH FLOW
-1449.21%
Balance Sheet Ingevity Corporation
image
Current Assets 436 M
Cash & Short-Term Investments 68 M
Receivables 141 M
Other Current Assets 227 M
Non-Current Assets 1.37 B
Long-Term Investments 87.3 M
PP&E 709 M
Other Non-Current Assets 572 M
3.77 %7.81 %12.57 %4.84 %39.31 %31.70 %Total Assets$1.8b
Current Liabilities 264 M
Accounts Payable 94.5 M
Short-Term Debt 78.2 M
Other Current Liabilities 91.4 M
Non-Current Liabilities 1.56 B
Long-Term Debt 1.38 B
Other Non-Current Liabilities 187 M
5.17 %4.28 %5.00 %75.33 %10.22 %Total Liabilities$1.8b
EFFICIENCY
Earnings Waterfall Ingevity Corporation
image
Revenue 1.41 B
Cost Of Revenue 952 M
Gross Profit 455 M
Operating Expenses 167 M
Operating Income 288 M
Other Expenses 718 M
Net Income -430 M
2b2b1b1b1b1b1b1b800m800m600m600m400m400m200m200m00(200m)(200m)(400m)(400m)(600m)(600m)1b(952m)455m(167m)288m(718m)(430m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
32.33% GROSS MARGIN
32.33%
20.48% OPERATING MARGIN
20.48%
-30.60% NET MARGIN
-30.60%
-220.44% ROE
-220.44%
-21.27% ROA
-21.27%
14.30% ROIC
14.30%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Ingevity Corporation
image
250m250m200m200m150m150m100m100m50m50m00(50m)(50m)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -430 M
Depreciation & Amortization 108 M
Capital Expenditures -77.6 M
Stock-Based Compensation 11.9 M
Change in Working Capital -200 K
Others 499 M
Free Cash Flow 51 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Ingevity Corporation
image
Wall Street analysts predict an average 1-year price target for NGVT of $47.5 , with forecasts ranging from a low of $42 to a high of $56 .
NGVT Lowest Price Target Wall Street Target
42 USD 32.62%
NGVT Average Price Target Wall Street Target
47.5 USD 49.98%
NGVT Highest Price Target Wall Street Target
56 USD 76.82%
Price
Max Price Target
Min Price Target
Average Price Target
60605555505045454040353530302525Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 10
6. Ownership
Insider Ownership Ingevity Corporation
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Here's Why You Should Add Ingevity Stock to Your Portfolio NGVT benefits from the repositioning of its Performance Chemicals segment, strategic acquisitions and actions to drive growth. zacks.com - 4 weeks ago
Ingevity's Shares Up 10% in 6 Months: What's Driving the Stock? NGVT gains on the repositioning of its Performance Chemicals segment, strategic acquisitions and actions to drive growth. zacks.com - 1 month ago
Ingevity Files Definitive Proxy Statement and Issues Letter to Stockholders NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity today announced that it has filed its definitive proxy statement with the U.S. SEC in connection with its 2025 Annual Meeting. businesswire.com - 1 month ago
Why Is Ingevity (NGVT) Down 8.3% Since Last Earnings Report? Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock? zacks.com - 1 month ago
Why Ingevity (NGVT) is a Top Momentum Stock for the Long-Term Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. zacks.com - 1 month ago
Ingevity announces appointment of David H. Li as president and CEO NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity announced that its board of directors has appointed David H. Li as the company's president and CEO, effective as of April 7, 2025. businesswire.com - 1 month ago
Here's What Makes Ingevity Stock a Solid Choice Right Now NGVT benefits from the repositioning of its Performance Chemicals segment to rationalize its manufacturing footprint and strategic acquisitions. zacks.com - 1 month ago
Zacks Industry Outlook Axalta Coating, Ingevity and Flexible Solutions International Axalta Coating, Ingevity and Flexible Solutions International have been highlighted in this Industry Outlook article. zacks.com - 1 month ago
5 Stocks With Upgraded Broker Ratings Worth Betting on Now Brokers have more insights into stocks and the macroeconomic backdrop. One must follow broker rating upgrades to pick stocks like NGVT, STRL, NVDA, PYPL & AAL. zacks.com - 1 month ago
3 Chemical Specialty Stocks to Watch Amid Industry Challenges Soft end-market demand dampens the prospects of the Zacks Chemicals Specialty industry. AXTA, NGVT and FSI are set to gain from strategic actions to navigate the ongoing challenges. zacks.com - 1 month ago
Ingevity Highlights Significant Momentum on Actions Underway to Drive Improved Performance and Value Creation NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity Corporation (NYSE: NGVT) today issued the following letter to stockholders in response to the presentation issued by Vision One Management Partners (“Vision One”) earlier today: Dear Ingevity Stockholders, The Ingevity Board of Directors and leadership team are committed to taking aggressive actions to deliver significant, sustainable value creation for all Ingevity stockholders. Over the last year, we have undertaken a broad range of initiative. businesswire.com - 2 months ago
Ingevity's Q4 Earnings Beat Estimates, Revenues Down Y/Y NGVT's top line declines year over year in the fourth quarter due to the repositioning of the Performance Chemicals segment. zacks.com - 2 months ago
8. Profile Summary

Ingevity Corporation NGVT

image
COUNTRY US
INDUSTRY Chemicals - Specialty
MARKET CAP $ 1.15 B
Dividend Yield 0.00%
Description Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, motorcycles, trucks, and boats. This segment also produces other activated carbon products for use in various applications, including food, water, beverage, and chemical purification. The Performance Chemicals segment comprises of pavement technologies, industrial specialties, and engineered polymers. It manufactures products derived from crude tall oil and lignin extracted from the kraft pulping process, as well as caprolactone monomers and derivatives derived from cyclohexanone and hydrogen peroxide. This segment's products are used in various applications comprising warm mix paving, pavement preservation, pavement reconstruction and recycling, oil well service additives, oil production, and downstream applications; and adhesives, agrochemical dispersants, lubricants, printing inks, industrial intermediates and oilfield, coatings, resins, elastomers, bioplastics, and medical devices. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.
Contact 4920 O'Hear Avenue, North Charleston, SC, 29405 https://www.ingevity.com
IPO Date May 3, 2016
Employees 1600
Officers Mr. Stuart Edward Woodcock Jr. Executive Vice President & President of Performance Materials Mr. Ryan C. Fisher Senior Vice President, General Counsel & Secretary Mr. David H. Li President, Chief Executive Officer & Director Mr. Phillip John Platt Senior Vice President of Finance & Chief Accounting Officer Mr. Richard A. White Jr. Senior Vice President & President of Performance Chemicals Mr. Terrance M. Dyer Senior Vice President & Chief Human Resources Officer Ms. Mary Dean Hall Executive Vice President & Chief Financial Officer Caroline Monahan Director of Communications John E. Nypaver Jr. Vice President of Investor Relations & Treasurer Mr. Michael N. Shukov Senior Vice President & President of Advanced Polymer Technologies